Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy RZ358 (ersodetug) is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute’s mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation collaboration and integrity. Position Overview The Senior Director / Executive Director HCP Marketing will support strategy development and lead tactical execution focused on a new product launch in congenital hyperinsulinism (cHI). This role will report to the Vice-President Commercial Strategy and requires expertise in personal promotions and thought leader engagement as … Sign In to View